Elon Musk has vehemently denied recent allegations of drug abuse, specifically involving ketamine, during his 2024 presidential campaign. The claims, published by the New York Times, were swiftly refuted by Musk, who labeled the report as inaccurate.

While Musk acknowledged a past prescription for ketamine to manage mental health challenges, he emphasized that he hasn’t used the substance recently. The New York Times article linked Musk’s alleged drug use to reported health issues and cited instances of erratic behavior as evidence. This strong denial comes at a crucial point in Musk’s campaign, raising questions about the impact of such accusations on his public image and political prospects.

The ongoing debate highlights the complexities of public figures and mental health, and raises questions about the reporting of sensitive information, particularly in a highly charged political climate. The situation remains dynamic, with public attention focused on the accuracy of the New York Times report and Musk’s response.